Sfoglia per Rivista TARGETED ONCOLOGY
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study
2021-01-01 Hawkes, Eliza A; Phillips, Tycel; Budde, Lihua Elizabeth; Santoro, Armando; Saba, Nakhle S; Roncolato, Fernando; Gregory, Gareth P; Verhoef, Gregor; Offner, Fritz; Quero, Cristina; Radford, John; Giannopoulos, Krzysztof; Stevens, Don; Thall, Aron; Huang, Bo; Laird, A Douglas; Sandner, Robin; Ansell, Stephen M
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab
2024-01-01 Rimini, Margherita; Loi, Eleonora; Rizzato, Mario Domenico; Pressiani, Tiziana; Vivaldi, Caterina; Gusmaroli, Eleonora; Antonuzzo, Lorenzo; Martinelli, Erika; Garajova, Ingrid; Giordano, Guido; Lucchetti, Jessica; Schirripa, Marta; Cornara, Noemi; Rossari, Federico; Vitiello, Francesco; Amadeo, Elisabeth; Persano, Mara; Piva, Vittoria Matilde; Balsano, Rita; Salani, Francesca; Pircher, Chiara; Cascinu, Stefano; Niger, Monica; Fornaro, Lorenzo; Rimassa, Lorenza; Lonardi, Sara; Scartozzi, Mario; Zavattari, Patrizia; Casadei-Gardini, Andrea
Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT
2014-01-01 Di Bartolomeo, M; Pietrantonio, F; Perrone, F; Dotti, Kf; Lampis, A; Bertan, C; Beretta, E; Rimassa, L; Carbone, C; Biondani, P; Passalacqua, R; Pilotti, S; Bajetta, E
Management of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance
2020-01-01 Lorusso, D; García-Donas, J; Sehouli, J; Joly, F
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile
2021-01-01 Lorusso, Domenica; Maltese, Giuseppa; Sabatucci, Ilaria; Cresta, Sara; Matteo, Cristina; Ceruti, Tommaso; D'Incalci, Maurizio; Zucchetti, Massimo; Raspagliesi, Francesco; Sonetto, Cristina; Sinno, Valentina; Ronzulli, Dominique; Giolitto, Serena; de Braud, Filippo
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study
2018-01-01 Di Bartolomeo, M; Niger, M; Tirino, G; Petrillo, A; Berenato, R; Laterza, Mm; Pietrantonio, F; Morano, F; Antista, M; Lonardi, S; Fornaro, L; Tamberi, S; Giommoni, E; Zaniboni, A; Rimassa, L; Tomasello, G; Sava, T; Spada, M; Latiano, T; Bittoni, A; Bertolini, A; Proserpio, I; Bencardino, Kb; Graziano, F; Beretta, G; Galdy, S; Ventriglia, J; Scagnoli, S; Spallanzani, A; Longarini, R; De Vita, F
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
2023-01-01 Rimini, Margherita; Persano, Mara; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Piscaglia, Fabio; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Pressiani, Tiziana; Montes, Margarida; Vivaldi, Caterina; Soldà, Caterina; Hiraoka, Atsushi; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Burgio, Valentina; Rimassa, Lorenza; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis
2022-01-01 Rimini, Margherita; Burgio, Valentina; Antonuzzo, Lorenzo; Rimassa, Lorenza; Oneda, Ester; Lavacchi, Daniele; Personeni, Nicola; Ratti, Francesca; Pedica, Federica; Della Corte, Angelo; Persano, Mara; De Cobelli, Francesco; Aldrighetti, Luca; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea
Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience
2018-01-01 Alfieri, S.; Bergamini, C.; Granata, R.; Locati, L.; Licitra, L.; Bossi, P.
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study
2022-01-01 De Laurentiis, Michelino; Caputo, Roberta; Mazza, Manuelita; Mansutti, Mauro; Masetti, Riccardo; Ballatore, Zelmira; Torrisi, Rosalba; Michelotti, Andrea; Zambelli, Alberto; Ferro, Antonella; Generali, Daniele; Vici, Patrizia; Coltelli, Luigi; Fabi, Alessandra; Marchetti, Paolo; Ballestrero, Alberto; Spazzapan, Simon; Frassoldati, Antonio; Sarobba, Maria Giuseppina; Grasso, Donatella; Zamagni, Claudio
Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT
2014-01-01 Boers-Sonderen, Mj; de Geus-Oei, Lf; Desar, Ime; van der Graaf, Wta; Oyen, W; Ottevanger, Pb; van Herpen, Cml
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study | 1-gen-2021 | Hawkes, Eliza A; Phillips, Tycel; Budde, Lihua Elizabeth; Santoro, Armando; Saba, Nakhle S; Roncolato, Fernando; Gregory, Gareth P; Verhoef, Gregor; Offner, Fritz; Quero, Cristina; Radford, John; Giannopoulos, Krzysztof; Stevens, Don; Thall, Aron; Huang, Bo; Laird, A Douglas; Sandner, Robin; Ansell, Stephen M | |
| Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab | 1-gen-2024 | Rimini, Margherita; Loi, Eleonora; Rizzato, Mario Domenico; Pressiani, Tiziana; Vivaldi, Caterina; Gusmaroli, Eleonora; Antonuzzo, Lorenzo; Martinelli, Erika; Garajova, Ingrid; Giordano, Guido; Lucchetti, Jessica; Schirripa, Marta; Cornara, Noemi; Rossari, Federico; Vitiello, Francesco; Amadeo, Elisabeth; Persano, Mara; Piva, Vittoria Matilde; Balsano, Rita; Salani, Francesca; Pircher, Chiara; Cascinu, Stefano; Niger, Monica; Fornaro, Lorenzo; Rimassa, Lorenza; Lonardi, Sara; Scartozzi, Mario; Zavattari, Patrizia; Casadei-Gardini, Andrea | |
| Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT | 1-gen-2014 | Di Bartolomeo, M; Pietrantonio, F; Perrone, F; Dotti, Kf; Lampis, A; Bertan, C; Beretta, E; Rimassa, L; Carbone, C; Biondani, P; Passalacqua, R; Pilotti, S; Bajetta, E | |
| Management of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance | 1-gen-2020 | Lorusso, D; García-Donas, J; Sehouli, J; Joly, F | |
| Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile | 1-gen-2021 | Lorusso, Domenica; Maltese, Giuseppa; Sabatucci, Ilaria; Cresta, Sara; Matteo, Cristina; Ceruti, Tommaso; D'Incalci, Maurizio; Zucchetti, Massimo; Raspagliesi, Francesco; Sonetto, Cristina; Sinno, Valentina; Ronzulli, Dominique; Giolitto, Serena; de Braud, Filippo | |
| Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study | 1-gen-2018 | Di Bartolomeo, M; Niger, M; Tirino, G; Petrillo, A; Berenato, R; Laterza, Mm; Pietrantonio, F; Morano, F; Antista, M; Lonardi, S; Fornaro, L; Tamberi, S; Giommoni, E; Zaniboni, A; Rimassa, L; Tomasello, G; Sava, T; Spada, M; Latiano, T; Bittoni, A; Bertolini, A; Proserpio, I; Bencardino, Kb; Graziano, F; Beretta, G; Galdy, S; Ventriglia, J; Scagnoli, S; Spallanzani, A; Longarini, R; De Vita, F | |
| Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis? | 1-gen-2023 | Rimini, Margherita; Persano, Mara; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Piscaglia, Fabio; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Pressiani, Tiziana; Montes, Margarida; Vivaldi, Caterina; Soldà, Caterina; Hiraoka, Atsushi; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Burgio, Valentina; Rimassa, Lorenza; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea | |
| Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis | 1-gen-2022 | Rimini, Margherita; Burgio, Valentina; Antonuzzo, Lorenzo; Rimassa, Lorenza; Oneda, Ester; Lavacchi, Daniele; Personeni, Nicola; Ratti, Francesca; Pedica, Federica; Della Corte, Angelo; Persano, Mara; De Cobelli, Francesco; Aldrighetti, Luca; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea | |
| Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience | 1-gen-2018 | Alfieri, S.; Bergamini, C.; Granata, R.; Locati, L.; Licitra, L.; Bossi, P. | |
| Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study | 1-gen-2022 | De Laurentiis, Michelino; Caputo, Roberta; Mazza, Manuelita; Mansutti, Mauro; Masetti, Riccardo; Ballatore, Zelmira; Torrisi, Rosalba; Michelotti, Andrea; Zambelli, Alberto; Ferro, Antonella; Generali, Daniele; Vici, Patrizia; Coltelli, Luigi; Fabi, Alessandra; Marchetti, Paolo; Ballestrero, Alberto; Spazzapan, Simon; Frassoldati, Antonio; Sarobba, Maria Giuseppina; Grasso, Donatella; Zamagni, Claudio | |
| Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT | 1-gen-2014 | Boers-Sonderen, Mj; de Geus-Oei, Lf; Desar, Ime; van der Graaf, Wta; Oyen, W; Ottevanger, Pb; van Herpen, Cml |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile